State Street Corp Castle Biosciences Inc Transaction History

State Street Corp

$2.36 Trillion
Q1 2025

A detailed history of State Street Corp transactions in Castle Biosciences Inc stock. As of the latest transaction made, State Street Corp holds 715,028 shares of CSTL stock, worth $11.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

715,028

Previous 710,212 0.68%

Holding current value

$11.5 Million

Previous $18.9 Million 24.37%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$18.76 - $32.72 $90,348 - $157,579	4,816 Added 0.68%	715,028 $14.3 Million
Q4 2024 Feb 14, 2025	BUY	$26.52 - $34.67 $801,195 - $1.05 Million	30,211 Added 4.44%	710,212 $18.9 Million
Q3 2024 Nov 14, 2024	BUY	$17.4 - $31.47 $1.06 Million - $1.92 Million	60,924 Added 9.84%	680,001 $19.4 Million
Q2 2024 Aug 14, 2024	BUY	$18.84 - $24.94 $250,157 - $331,153	13,278 Added 2.19%	619,077 $13.5 Million
Q1 2024 May 15, 2024	BUY	$18.06 - $25.3 $467,410 - $654,789	25,881 Added 4.46%	605,799 $13.4 Million
Q4 2023 Feb 14, 2024	BUY	$12.19 - $22.43 $179,851 - $330,932	14,754 Added 2.61%	579,918 $12.5 Million
Q3 2023 Nov 14, 2023	BUY	$13.28 - $20.3 $396,222 - $605,670	29,836 Added 5.57%	565,164 $9.55 Million
Q2 2023 Aug 14, 2023	BUY	$11.66 - $26.0 $149,248 - $332,800	12,800 Added 2.45%	535,328 $7.34 Million
Q1 2023 May 15, 2023	BUY	$19.47 - $28.49 $351,920 - $514,956	18,075 Added 3.58%	522,528 $11.9 Million
Q4 2022 Feb 14, 2023	BUY	$18.08 - $30.0 $118,026 - $195,840	6,528 Added 1.31%	504,453 $11.9 Million
Q3 2022 Nov 15, 2022	SELL	$22.51 - $34.32 $148,543 - $226,477	-6,599 Reduced 1.31%	497,925 $13 Million
Q2 2022 Aug 15, 2022	BUY	$16.0 - $45.99 $733,104 - $2.11 Million	45,819 Added 9.99%	504,524 $11.1 Million
Q1 2022 May 16, 2022	BUY	$33.17 - $46.98 $88,431 - $125,248	2,666 Added 0.58%	458,705 $20.6 Million
Q4 2021 Feb 14, 2022	BUY	$39.06 - $67.58 $828,150 - $1.43 Million	21,202 Added 4.88%	456,039 $19.6 Million
Q3 2021 Nov 15, 2021	BUY	$60.13 - $77.6 $236,852 - $305,666	3,939 Added 0.91%	434,837 $28.9 Million
Q2 2021 Aug 16, 2021	BUY	$50.07 - $76.78 $6.28 Million - $9.63 Million	125,419 Added 41.06%	430,898 $31.6 Million
Q1 2021 May 17, 2021	BUY	$58.92 - $97.33 $2.6 Million - $4.29 Million	44,056 Added 16.85%	305,479 $20.9 Million
Q4 2020 Feb 16, 2021	BUY	$43.6 - $73.05 $2.32 Million - $3.89 Million	53,303 Added 25.61%	261,423 $17.6 Million
Q3 2020 Nov 10, 2020	BUY	$38.47 - $52.03 $817,949 - $1.11 Million	21,262 Added 11.38%	208,120 $10.7 Million
Q2 2020 Aug 14, 2020	BUY	$27.28 - $43.01 $1.01 Million - $1.59 Million	36,879 Added 24.59%	186,858 $7.04 Million
Q1 2020 May 11, 2020	BUY	$23.08 - $35.53 $3.46 Million - $5.33 Million	149,979 New	149,979 $4.47 Million

Others Institutions Holding CSTL

# of Institutions

192

Shares Held

26.5M

Call Options Held

9.5K

Put Options Held

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $423M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Castle Biosciences Inc Transaction History